Mitotic catastrophe heterogeneity: implications for prognosis and immunotherapy in hepatocellular carcinoma.

Front Immunol · 2024 · PMC11250588 · PMID 39015573

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In the GSE223201 cohort, the MCGs risk score showed a decreasing trend in lenvatinib-treated HCC liver cancer compared to untreated patients ( Supplementary Figure S7D ), which was also observed in the GSE153203 cohort ( Supplementary Figure S7E ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.